Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shalaks Pharmaceuticals Pvt. Ltd.

www.shalaks.com

Latest From Shalaks Pharmaceuticals Pvt. Ltd.

Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q4 2011

Biopharmaceutical company financings more than doubled to $2.7 billion from Q3. There were 23 acquisitions bringing in a total of $17.7 billion. And in alliances there was a focus on biosimilars, oncology and neurology deals, and unique partnerships with clear paths to exits.

BioPharmaceutical Deals

Invida CEO John Graham On Commercializing Products In Asia: An Interview With PharmAsia News (Part 2 of 2)

On the sidelines of the JP Morgan Healthcare Conference, Graham talks about Menarini’s acquisition of Invida, plans for expansion in China and India, and his favorite non-BRIC emerging markets.

BioPharmaceutical Asia Pacific

Invida CEO John Graham On Commercializing Products In Asia: An Interview With PharmAsia News (Part 1 of 2)

On the sidelines of the JP Morgan Healthcare Conference, Graham talks about Menarini’s acquisition of Invida, plans for expansion in China and India, and his favorite non-BRIC emerging markets.

BioPharmaceutical Asia Pacific

Deals Shaping The Medical Industry (01/2012)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Dermatology
  • Infectious & Viral Diseases
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Shalaks Pharmaceuticals Pvt. Ltd.
  • Senior Management
  • Contact Info
  • Shalaks Pharmaceuticals Pvt. Ltd.
    Phone: 11 2592
    C-3 Puja House
    Milan Complex
    New Delhi, 110015
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register